FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Key updates from the CDC’s new lab recommendations for syphilis testing.
Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.
A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.
Recent study provides new details on how COVID-19 impacted cancer deaths in the US early in the pandemic and which groups were most affected.